IP Library Granted Patent US 9,375,513
Granted Patent B2
US 9,375,513 · App. 13/446,422 · Granted Jun 28, 2016

Regenerative materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,513
App. No.
13/446,422
Granted
Jun 28, 2016
Kind
B2
Abstract

Methods of making tissue fillers are provided. In certain embodiments, the tissue is flake-like and has regenerative properties.

Claims (29)

1. A method for preparing a tissue matrix composition comprising:

selecting a collagen-based tissue matrix;

contacting the tissue matrix with a cryoprotectant solution;

freezing the tissue matrix and cryoprotective solution;

cutting the frozen tissue matrix and cryoprotective solution into a plurality of cut tissue pieces having irregular size and shape, wherein the temperature of the tissue matrix ranges from −10 ° C. to −40° C. for the cutting step and wherein the cut tissue has a size distribution ranging from 0.2-5 mm in length, 0.2-3 mm in width, and 0.02-0 3 mm in thickness;

placing the plurality of cut tissue pieces into a liquid to form a suspension of interconnected irregularly shaped particles, and

removing liquid from the suspension to form a device having inter-connected channels that permit body fluid to flow freely therethrough.

2. The method of claim 1 , wherein the tissue matrix comprises an acellular tissue matrix.

3. The method of claim 2 , wherein the acellular tissue matrix comprises an acellular dermal matrix.

4. The method of claim 2 , wherein the acellular tissue matrix comprises an acellular porcine dermal matrix.

5. The method of claim 1 , wherein the cryoprotectant solution comprises at least one of a maltodextrin, sucrose, polyethylene glycol (PEG), or polyvinylpyrrolidone (PVP) solution, or a combination thereof.

6. The method of claim 1 , wherein the cryoprotectant solution comprises a maltodextrin solution.

7. The method of claim 6 , wherein the maltodextrin solution comprises 5-50% (w/v) maltodextrin.

8. The method of claim 6 , wherein the maltodextrin solution comprises 15-25% (w/v) maltodextrin.

9. The method of claim 1 , wherein cutting comprises grating.

10. The method of claim 1 , wherein the tissue matrix is cut with a grater.

11. The method of claim 1 , wherein the tissue matrix is cut with a grating wheel.

12. The method of claim 1 , further comprising exposing the tissue matrix to a disinfectant.

13. The method of claim 12 , wherein the disinfectant is isopropyl alcohol.

14. The method of claim 1 , further comprising sterilizing the plurality of cut tissue pieces by application of at least one of ethylene oxide, propylene oxide, gamma irradiation or e-beam irradiation.

15. The method of claim 1 , further comprising adding a bioactive substance to the cut matrix.

16. The method of claim 15 , wherein the bioactive substance comprises an antimicrobial agent.

17. The method of claim 15 , wherein the bioactive substance comprises a cytokine.

18. The method of claim 15 , wherein the bioactive substance comprises a growth factor.

19. The method of claim 15 , wherein the bioactive substance comprises non-collagenous tissue.

20. The method of claim 19 , wherein the non-collagenous tissue comprises adipose tissue.

21. The method of claim 15 , wherein the bioactive substance comprises cells.

22. The method of claim 21 , wherein the cells comprise stem cells.

23. The method of claim 1 , wherein removing liquid comprises freeze-drying the suspension.

Assignments (7)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 24, 2012
From: SUN, WENQUAN; BOWLEY, MELISSA RICHTER; GOEL, RAGHAV
To: LIFECELL CORPORATION
Reel/Frame 028624/0255 →